Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple MyelomaNeha Korde, Ola Landgren, Mark Roschewski et al.|JAMA Oncology|2015Cited by 309
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemiaDeepa Bhojwani, Susan R. Rheingold, Maureen M. O’Brien et al.|Leukemia|2018Cited by 209
Minimal residual disease in multiple myeloma: bringing the bench to the bedsideSham Mailankody, Ola Landgren, Neha Korde et al.|Nature Reviews Clinical Oncology|2015Cited by 114